Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123226) titled 'Prognostic Value of New Biomarker on Adverse Renal Outcomes in High-Risk Cardiac surgery Patients' on April 23.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Zhongshan Hospital, Fudan University
Condition:
Cardiac Surgery Associated Acute Kidney Injury
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-23
Target Sample Size: Case series :1491;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=319990
Disclaimer: Curated by HT Syndication....